Sharda Cropchem (SHARDACROP) Q4 24/25 earnings summary

Executive summary

• Q4 and FY25 saw strong revenue and profit growth, driven by higher volumes in agrochemicals across all major regions and product categories.

• The company operates an asset-light, IP-driven model, focusing on global marketing and distribution of generic agrochemicals in 80+ countries.

• Management continues to invest in product registrations, expand its sales force, and deepen market penetration.

• Board approved audited consolidated and standalone results for FY25 with no audit qualifications; final dividend of Rs. 6 per share recommended.

Financial highlights

• Q4 FY25 revenue grew 39% YoY to Rs. 1,829 crore; FY25 revenue up 37% to Rs. 4,320 crore.

• Q4 FY25 EBITDA up 16% to Rs. 352 crore; FY25 EBITDA more than doubled to Rs. 682 crore (margin 15.8%).

• FY25 PAT surged to Rs. 304 crore from Rs. 32 crore in FY24; EPS at Rs. 33.74, up from Rs. 3.53.

• Cash and equivalents increased to Rs. 558 crore as of March 2025.

• Board recommended a final dividend of Rs. 6 per share for FY25.

Outlook and guidance

• Management targets over 15% top-line growth in FY26, with gross margins expected to improve as prices recover.

• EBITDA margin guidance maintained at 15%-18% for FY26.

• Price and product mix expected to recover, with a 10%-15% price increase anticipated.

• Performance remains sensitive to cropping patterns and weather globally.